Anatomy of a Shortage: Tracing the Recurring Supply Crises That Have Left American Azithromycin Patients Without Options
Azithromycin shortages in the United States are not isolated incidents — they follow a recognizable, troubling pattern rooted in manufacturing vulnerabilities, regulatory pressure, and global supply chain fragility. This investigation traces the historical arc of these disruptions and examines what patients and policymakers can do to prepare for the next inevitable gap in supply.